Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. - Wikidata - awgldk - TriplyDB

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

http://www.wikidata.org/entity/Q37957562

about

Mechanisms of sympathetic regulation in orthostatic intolerance A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease Potential Interactions between the Autonomic Nervous System and Higher Level Functions in Neurological and Neuropsychiatric Conditions Update on the theory and management of orthostatic intolerance and related syndromes in adolescents and children Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model Vesicular integrity in Parkinson's disease Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism Autonomic Dysfunction: How to Identify and When to Treat?Fuzzy logic-based risk of fall estimation using smartwatch data as a means to form an assistive feedback mechanism in everyday living activities.Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.Diagnosing and treating neurogenic orthostatic hypotension in primary care.Etiology of Syncope and Unexplained Falls in Elderly Adults with Dementia: Syncope and Dementia (SYD) Study.Dysautonomia in Parkinson disease An overview on the correlation of neurological disorders with cardiovascular disease.Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease Learning on Jupiter, learning on the Moon: the dark side of the G-force. Effects of gravity changes on neurovascular unit and modulation of learning and memory Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein.Prediction of orthostatic hypotension in multiple system atrophy and Parkinson disease Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson's Disease.Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.Cardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stability Dopamine D2R Agonist-Induced Cardiovascular Effects in Healthy Male Subjects: Potential Implications in Clinical Settings.Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.Complexity Variability Assessment of Nonlinear Time-Varying Cardiovascular Control.Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.Parkinson's Disease: From Pathogenesis to Pharmacogenomics Management approaches to hypertension in autonomic failure.Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.Management of orthostatic hypotension in patients with Parkinson's disease.The relevance of pre-motor symptoms in Parkinson's disease.Studying the pathophysiologic connection between cardiovascular and nervous systems using stem cells.Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.Spine Topographical Distribution of Skin α-Synuclein Deposits in Idiopathic Parkinson Disease.Role of peripheral vascular resistance as an indicator of cardiovascular abnormalities in patients with Parkinson's disease.Orthostatic hypotension is associated with decreased cerebrospinal fluid levels of chromogranin A in early stage of Parkinson disease.

P2860

Q24599369-EDADCDD7-81B3-4495-90A0-74823648353D Q26744733-5C5916D8-DAB8-4802-8059-F8A78DEF3807 Q26778937-DBEF9CD6-AB85-4FCF-9A3E-A9DFF6C439C3 Q26782934-D204C576-CAEC-4177-82C9-FB1B7502933D Q26864466-009098B2-A476-425C-8481-EC4997C41F8C Q26999386-01707158-4541-4E10-95D8-358CD093CD72 Q27025731-92F303C5-1A92-47A5-AFE0-57DC295BBEDF Q28384426-226CDB8A-17C2-42C6-ACD8-7D35DF62A321 Q28385737-9C54AA82-6315-4975-A9CC-B3A009C70B72 Q28468282-39677BEA-7612-4F6F-94AF-2EEC5F448500 Q30249356-5E68BA84-88B1-49F1-9836-BCB3C2F861D4 Q31150885-1B92090E-8C3F-4CC5-A816-F14B837FF55F Q33164125-CD254FC2-9A73-4969-8044-F99FF4323B9A Q33165773-B4641D86-19CA-4B1C-9B44-333ADA807467 Q33167349-00F62EFE-1210-410C-90A6-E563AD8E5CE6 Q34463831-DE71702A-6755-4663-B6E4-DC6F8AC9605F Q34800195-082F1EE9-BFDF-4120-9732-973EED8491B6 Q35931289-9E8E9070-4FB0-4E25-AC1E-4ED9EC5EA7ED Q36011221-E87880BF-6597-4A63-A636-02AC0E6F4FD1 Q36252230-20EAFA6A-6D49-4BA1-8EB9-878DF0C153BC Q36254073-8302942E-7055-4AD9-8221-81FCA083F0F6 Q36400251-5B0D199C-1863-440B-88C1-96C987F7836E Q36574394-FA51E2EF-A851-4462-B5F4-A016C19DD761 Q36949488-5F92333A-031F-467D-B8AA-18FC5ABE5E8E Q36992085-C287DBBA-0C4E-482C-BDC4-7AB132616FBC Q37309358-149D4747-197D-439B-A989-95DB3EB2EC5D Q37576818-89F64DF5-59EA-4315-B25B-2B6CBAAFCBC2 Q37593555-40A046EA-D871-4703-ACCE-899BF4348159 Q37652208-521A22EA-F47B-4FFA-9EC1-9DECAFFCBF6B Q37711062-68125281-EB51-4E2C-ABAD-A6728A767E95 Q37729129-EB39AE00-C502-473F-9FA1-DF96BFE7FC8C Q38026735-6A80B1FB-CB94-45E0-9572-56639877BAA7 Q38204871-BCE09A34-C517-4E48-9477-61CF589E3F01 Q38285642-9A7B4D4E-E7B8-4356-8A79-00528524D1ED Q38594857-9A0F497F-981F-4615-9CB9-8CECA1EB9F56 Q38740457-4D746949-713E-4153-8BC2-78FD7A94DA2B Q38754617-37CB5179-0DDA-477A-BF43-BFE6687CD59E Q38840638-57520A52-09A6-484F-B5F8-08A7B851E0C4 Q40133555-BEF3FA8E-2EA5-444D-94DA-AD7A60FCA107 Q41375590-04D75E2B-BA31-4A9F-8932-48D77C91CF93

P2860

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

http://www.wikidata.org/entity/Q37957562

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

@en

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

@nl

type

label

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

@en

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

@nl

prefLabel

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

@en

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

@nl

P1433

Q37957562-51B4D8AF-4F76-4686-A489-0421C05AB33E

P1476

Q37957562-6AA5F97B-CC56-465C-BC76-A8EA8142D748

P2093

Q37957562-1BA99D91-2ADC-469F-BE8C-C30107EF8247

Q37957562-40C249E2-A4F8-46F4-AA0E-0FF6B6EDC0D3

P2860

Q37957562-0239D81E-C9BE-485B-A974-75BCE9E67CA9

Q37957562-07EC4633-A823-4A5C-8C38-5CC8ED7B0D7A

Q37957562-0C455941-4E74-4624-9189-241A471F2B88

Q37957562-120278C2-B72D-4B8A-B66D-8859577053A1

Q37957562-1B997457-276B-4907-A15D-9D142CE549EF

Q37957562-25D1021B-C77A-4DF8-B73B-484AF9C0CDA2

Q37957562-25D45570-9EED-4EE3-98B2-22C085486573

Q37957562-283241DA-F04A-495F-A8A7-482C1152B15F

Q37957562-3EE96305-0D7B-4368-9EC9-0FA40C6C29E4

Q37957562-46FB1B98-A510-42E7-A4B6-B1C3F0A96A0F

P304

Q37957562-CACC6F72-D34A-4560-A632-D66711C3F17F

P31

Q37957562-219D60AE-F664-4F52-B20E-F3BBD92F01EB

P356

Q37957562-F90FF5BD-983A-406F-8DF6-EAF2C2E8165B

P433

Q37957562-04F0BCC3-E4A4-4557-A633-1605EE148C85

P478

Q37957562-96C10244-3CD6-4303-9BD3-7B41C0244AD2

P577

Q37957562-7F51433A-7B17-412E-8BC9-E5B9CF39EA19

P5875

Q37957562-FF18935C-FA4A-403B-BE1C-9F4DFBD2C9F4

P698

Q37957562-4ADB5D39-20BF-4D23-84E4-236BC6AA89EB

P921

Q37957562-2488DCF3-60AB-4CDD-A410-D4A97D93D8E3

Q37957562-43FBE832-84E7-49BB-B6E8-B62BFF97562C

Q37957562-8C48A130-207D-4E98-9609-95FCDE876319

Q37957562-C7B41970-5C6C-4699-88D8-F1F9B346586D

P932

Q37957562-C3567140-4426-4328-8E37-A385651CF8CF

P356

J.NBD.2011.10.025

P1433

Neurobiology of Disease

P1476

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

@en

P2093

David S Goldstein

http://www.w3.org/2001/XMLSchema#string

Samay Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration

Stages in the development of Parkinson's disease-related pathology

Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.

Association of anosmia with autonomic failure in Parkinson disease.

Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity

The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

Norepinephrine precursor therapy in neurogenic orthostatic hypotension.

Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab

Cardiac sympathetic neuroimaging: summary of the First International Symposium.

Neurogenic orthostatic hypotension: a pathophysiological approach

P304

572-580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2011.10.025

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51806705

http://www.w3.org/2001/XMLSchema#string

P698

22094370

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

Parkinson's disease

pathophysiology

P932

3299874

http://www.w3.org/2001/XMLSchema#string